We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
An independent tribunal responsible for handling appeals against decisions made by the Secretary of State for Health and Social Care from pharmaceutical companies.
An agreement between DHSC and the ABPI on getting the best value and most effective medicines into use more quickly.
Controlled drugs and precursor chemicals licensing fees information for individuals and companies.
Seeks views on proposals to change to how prices of branded NHS medicines are determined and re-align savings alongside PPRS.
How to use an economic evaluation to evaluate your digital health product.
Resources to help local commissioners achieve value for money by estimating the return on investment (ROI) and cost-effectiveness of public health programmes.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2023.
This consultation seeks views on proposals to update the statutory scheme to control the cost of branded health service medicines.
This consultation considers the proposed review of the statutory scheme to control the cost of branded health service medicines.
Helping public health practitioners conducting evaluations – using economic evaluation to identify the value gained from an intervention.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2021.
Guidance for UK wholesalers and manufacturers on how to import human medicines including unlicensed medicines, how to apply for a licence and how much it costs.
Apply for a promising innovative medicine (PIM) designation or scientific opinion for your medicine from MHRA.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Guidance on how to license electronic cigarettes and other inhaled nicotine-containing products (NCPs) as medicines in the UK.
This brief considers the main regulatory frameworks and the scope for achieving better access to medicines
Pharmacy, prescription-only (POM), and general sale list (GSL) medicines: apply to move your medicine to a different classification.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).